BGC > Buscar Producto > Lenvatinib mesylate | 857890-39-2

Molecular Formula: C22H23ClN4O7S
Molecular Weight: 522.95862

Description:
Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that has selectivity for VEGFR2. It exhibits antineoplastic activity, and has been indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer.

• Molecular Weight:522.96
• Melting Point:>220°C (dec.)
• Purity:≥95%

Molecular Formula:
C21H19ClN4O4.CH4O3S
Canonical SMILES:
COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O
InChI:
InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)
InChIKey:
HWLFIUUAYLEFCT-UHFFFAOYSA-N
Solubility:
Soluble in DMSO (Slightly), Methanol (Slightly)
Appearance:
White to Light Beige Solid
Application:
Antineoplastic Agents
Storage: Store at -20°C
Synonyms:
4-[3-Chloro-4-[(cyclopropylaminocarbonyl)amino]phenoxy]-7-methoxy-6-quinolinecarboxamide Mesylate; E 7080 Mesylate; Kisplyx; Lenvatinib Mesylate; Lenvatinib Methanesulfonate; Lenvima; N-(4-((6-Carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)-N'-cyclopropylurea monomethanesulfonate; 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, methanesulfonate (1:1)